Merckformin Xr (Metformin Hydrochloride)

Metformin Hydrochloride reduces hepatic glucose production by inhibiting mitochondrial complex I, which lowers gluconeogenesis. It also increases peripheral insulin sensitivity, enhancing glucose uptake in muscle and fat tissue, and modestly decreases intestinal glucose absorption, together helping to lower blood glucose levels.

The appropriate dose of Merckformin Xr is individualized by the prescribing healthcare professional based on the patient’s renal function, glycaemic targets, concomitant medications, and overall clinical condition. Dosage adjustments are made according to clinical response and tolerability.

Metformin is classified as a pregnancy category that should be used only when the potential benefits justify any potential risk to the fetus. It is excreted in breast milk in small amounts; breastfeeding mothers should discuss risks and benefits with their healthcare provider before continuing therapy.

To place an order, submit an enquiry on the Merckformin Xr product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with sulfonylureas or insulin, metformin (the active ingredient in Merckformin Xr) does not cause hypoglycaemia when used alone and is weight‑neutral or may promote modest weight loss. It is often first‑line therapy for type 2 diabetes because of its efficacy, safety profile, and low cost.

Merckformin Xr should be stored at temperatures below 25 °C in a dry place. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging is tightly closed to maintain product stability.

Merckformin Xr is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a full glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional and not crush or chew the tablets.

The most serious adverse reaction is lactic acidosis, a rare but life‑threatening condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute illness. Other serious risks include severe skin reactions such as Stevens‑Johnson syndrome and significant vitamin B12 deficiency with long‑term use.

Merckformin Xr is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those with severe hepatic disease. Caution is also advised for elderly patients and those with conditions predisposing to hypoxia.